Ras	O
p21	O
onco	O
-	O
protein	O
in	O
the	O
sera	B-Organism_substance
of	O
mice	O
carrying	O
an	O
experimentally	O
induced	O
tumor	B-Cancer
and	O
in	O
human	O
cancer	B-Cancer
patients	O
.	O

We	O
have	O
established	O
a	O
model	O
system	O
to	O
detect	O
the	O
presence	O
of	O
ras	O
p21	O
in	O
the	O
sera	B-Organism_substance
of	O
Balb	O
/	O
c	O
mice	O
carrying	O
tumors	B-Cancer
induced	O
by	O
a	O
mouse	O
cell	B-Cell
line	I-Cell
transformed	O
with	O
the	O
Harvey	O
murine	O
sarcoma	O
virus	O
in	O
the	O
presence	O
of	O
a	O
helper	O
Friend	O
murine	O
leukemia	O
virus	O
.	O

As	O
determined	O
by	O
ELISA	O
and	O
immunoblot	O
assays	O
,	O
ras	O
p21	O
in	O
the	O
serum	B-Organism_substance
increased	O
with	O
increased	O
tumor	B-Cancer
growth	O
.	O

Since	O
ras	O
genes	O
have	O
been	O
found	O
to	O
be	O
frequently	O
activated	O
in	O
human	O
tumours	B-Cancer
,	O
we	O
examined	O
the	O
levels	O
of	O
ras	O
p21	O
in	O
the	O
sera	B-Organism_substance
of	O
a	O
variety	O
of	O
human	O
cancer	B-Cancer
patients	O
.	O

In	O
only	O
3	O
out	O
of	O
13	O
cases	O
,	O
representing	O
patients	O
with	O
adenocarcinomas	B-Cancer
of	O
the	O
stomach	B-Organ
receiving	O
chemotherapy	O
,	O
was	O
ras	O
p21	O
detected	O
at	O
elevated	O
levels	O
,	O
whereas	O
in	O
patients	O
with	O
the	O
following	O
types	O
of	O
cancer	B-Cancer
no	O
substantial	O
change	O
in	O
serum	B-Organism_substance
ras	O
p21	O
was	O
observed	O
;	O
nine	O
with	O
breast	B-Cancer
,	O
5	O
colon	B-Cancer
,	O
5	O
lung	B-Cancer
,	O
5	O
ovarian	B-Cancer
and	O
5	O
hepatocellular	B-Cancer
carcinomas	I-Cancer
.	O

